Publication for ARHGAP4 and ARHGAP9

Species	Symbol	Function*	Entrez Gene ID*	Other ID	Gene coexpression	CoexViewer
hsa	ARHGAP4	Rho GTPase activating protein 4	393			[link]
hsa	ARHGAP9	Rho GTPase activating protein 9	64333

Pubmed ID	Priority	Text
28949383	0.98	ARHGAP4 and ARHGAP9; module 2, GlycoProtein VI-mediated activation cascade pathway was enriched with RHOG; module 3, Thromboxane A2 receptor signaling, Chemokine signaling pathway, CXCR4-mediated signaling events pathways were enriched with LYN, the hub gene of module 3.
	0.98	ARHGAP4, ARHGAP9, RHOG, ACTB, MYH9 and LYN in granulosa cell samples of polycystic ovary syndrome (PCOS) patients and normal controls as detected using RT-PCR. *P<0.05 compared to control.
	0.97	ARHGAP4, ARHGAP9, RHOG and LYN may be involved in the pathogenesis of PCOS.
	0.97	ARHGAP)4 and ARHGAP9 are involved in the Regulation of RhoA activity and Signaling by Rho GTPase pathways.
	0.93	ARHGAP4 and ARHGAP9 were markedly increased in PCOS IR patients relative to PCOS non-IR patients by using RT-PCR.
	0.93	ARHGAP4, ARHGAP9 and RHOG are promising candidate genes in PCOS, and may be recommended as possible therapeutic targets for PCOS.
	0.93	ARHGAP4, ARHGAP9, RHOG, ACTB, MYH9 and LYN in granulosa cell samples of polycystic ovary syndrome (PCOS) non-IR patients, PCOS IR patients and normal controls as detected using RT-PCR. *P<0.05 compared to the control; #P<0.05 compared to PCOS non-IR patients.
	0.90	ARHGAP4, ARHGAP9, RHOG, ACTB, MYH9 and LYN were upregulated DEGs in PCOS samples relative to normal samples.
	0.63	ARHGAP4, ARHGAP9, RHOG and LYN were significantly upregulated in PCOS.
	0.60	ARHGAP4, ARHGAP9, RHOG and LYN at the mRNA level were significantly increased in PCOS compared to levels in the normal controls (P<0.05).
	0.58	ARHGAP4 and ARHGAP9 were significantly upregulated in PCOS.
31788076	0.91	ARHGAP9, 11, 15, 18 and 30 were upregulated, and ARHGAP4, 8, 25 and 29 exhibited no dysregulation.
25224594	0.52	10C, AA/C1 and RG/C1 all expressed both VEGF-A165 and VEGF-A165b, immunoprecipitation with an anti-TIA-1 antibody pulled down only VEGF-A165 in AA/C1 and RG/C1 (cells expressing only flTIA-1), but no VEGF-A mRNA in sTIA-1 expressing cell lines (10C, HCA7 and LS174t, Figure 2H).